Search Results
Search for other papers by Thomas J Giordano in
Google Scholar
PubMed
of tumor classification schemes. Together with the identification of novel genetic alterations, these results have profound implications for the treatment of cancer patients. Tumors of endocrine organs are similarly genomic diseases. Compared to
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
-induced colorectal cancer ( Valko et al . 2001 ). One potential consequence of this event may be DNA damage by ROS, resulting in mutagenic genetic alterations that can initiate carcinogenesis and development of cancer. Perhaps such genetic alterations could include
Search for other papers by Segolene Hescot in
Google Scholar
PubMed
Search for other papers by Abir Al Ghuzlan in
Google Scholar
PubMed
Search for other papers by Theophraste Henry in
Google Scholar
PubMed
Search for other papers by Hala Sheikh-Alard in
Google Scholar
PubMed
Search for other papers by Livia Lamartina in
Google Scholar
PubMed
Search for other papers by Isabelle Borget in
Google Scholar
PubMed
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Eric Baudin in
Google Scholar
PubMed
Search for other papers by Corinne Dupuy in
Google Scholar
PubMed
Search for other papers by Alyaksandr V Nikitski in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Department of Endocrinology, Hôpitaux Universitaires de Genève, Geneva, Switzerland
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
) presence of at least one of the following criteria: ≥3 mitoses/10 high-power field (HPF), necrosis or convoluted nuclei and (iv) absence of nuclear features of papillary thyroid carcinoma ( Volante et al. 2007 ). Genetic profile of PDTC is different from
Search for other papers by Tirtha K Das in
Google Scholar
PubMed
Search for other papers by Ross L Cagan in
Google Scholar
PubMed
have a clear fish ortholog ( Howe et al . 2013 ). Morpholino-mediated transient gene knockdown and CRISPR-mediated endogenous gene alteration provide the ability to perform a spectrum of genetic manipulations in the fish. With these advantages
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Hypertension clearly stated that genetic studies should be considered for any patient diagnosed with PGL because these tumors carry the highest known heritability rate of any human neoplasm and because genetic alterations currently explain almost 80% of all
Search for other papers by Jacob A Quaytman in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Elena Morariu in
Google Scholar
PubMed
( Nicholson et al. 2019 ). However, to take full advantage of molecular testing, more information is needed on the outcomes of thyroid nodules with various genetic alterations. The results of this study show that patients with isolated PTEN mutations are
Search for other papers by Esther Korpershoek in
Google Scholar
PubMed
Departments of Pathology, Neurology, Department of Paediatric Oncology and Haematology, Josephine Nefkens Institute, Erasmus Medical Centre, University Medical Centre Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
Search for other papers by Nanne K Kloosterhof in
Google Scholar
PubMed
Search for other papers by Angelique Ziel-van der Made in
Google Scholar
PubMed
Search for other papers by Hanneke Korsten in
Google Scholar
PubMed
Search for other papers by Lindsey Oudijk in
Google Scholar
PubMed
Search for other papers by Jan Trapman in
Google Scholar
PubMed
Search for other papers by Winand N M Dinjens in
Google Scholar
PubMed
Search for other papers by Ronald R de Krijger in
Google Scholar
PubMed
appeared to be no difference in frequencies between benign or malignant tumours ( Petri et al . 2008 ). Genetic alterations have been investigated by CGH in two Pten KO mouse models ( You et al . 2002 , Korpershoek et al . 2009 ). The first study
Search for other papers by Xiaopei Shen in
Google Scholar
PubMed
Search for other papers by Rengyun Liu in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
Cancer Journal for Clinicians 65 5 – 29 . ( doi:10.3322/caac.21254 ) Sohn SY Park W-Y Shin H-T Bae JS Ki C-S Oh YL Kim SW Chung JH 2016 Highly concordant key genetic alterations in primary tumors and matched
Search for other papers by Tanupriya Contractor in
Google Scholar
PubMed
Search for other papers by Richard Clausen in
Google Scholar
PubMed
Search for other papers by Grant R Harris in
Google Scholar
PubMed
Search for other papers by Jeffrey A Rosenfeld in
Google Scholar
PubMed
Search for other papers by Darren R Carpizo in
Google Scholar
PubMed
Search for other papers by Laura Tang in
Google Scholar
PubMed
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA
Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Search for other papers by Chris R Harris in
Google Scholar
PubMed
novel promoter in mouse myoblasts . PLoS ONE e37923 . ( https://doi.org/10.1371/journal.pone.0037923 ) Wang GG Yao JC Worah S White JA Luna R Wu TT Hamilton SR Rashid A 2005 Comparison of genetic alterations in neuroendocrine
Search for other papers by Ann M Dorward in
Google Scholar
PubMed
Search for other papers by Kathryn L Shultz in
Google Scholar
PubMed
Search for other papers by Wesley G Beamer in
Google Scholar
PubMed
etiology of this pediatric cancer ( Kalfa et al. 2005 ). The low frequency of juvenile-type GC tumor appearance in the general population has motivated researchers to utilize animal models for investigations of the genetic and hormonal stimuli that